These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 32386581)

  • 21. How an immunologist pivoted to tackle COVID-19.
    Couzin-Frankel J
    Science; 2020 Oct; 370(6516):514-515. PubMed ID: 33122364
    [No Abstract]   [Full Text] [Related]  

  • 22. The first infant case of COVID-19 acquired from a secondary transmission in Vietnam.
    Le HT; Nguyen LV; Tran DM; Do HT; Tran HT; Le YT; Phan PH
    Lancet Child Adolesc Health; 2020 May; 4(5):405-406. PubMed ID: 32213326
    [No Abstract]   [Full Text] [Related]  

  • 23. Coronavirus Disease 2019 Test Results After Clinical Recovery and Hospital Discharge Among Patients in China.
    Wu J; Liu X; Liu J; Liao H; Long S; Zhou N; Wu P
    JAMA Netw Open; 2020 May; 3(5):e209759. PubMed ID: 32442288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-time RT-PCR in COVID-19 detection: issues affecting the results.
    Tahamtan A; Ardebili A
    Expert Rev Mol Diagn; 2020 May; 20(5):453-454. PubMed ID: 32297805
    [No Abstract]   [Full Text] [Related]  

  • 25. Viral load of SARS-CoV-2 in clinical samples.
    Pan Y; Zhang D; Yang P; Poon LLM; Wang Q
    Lancet Infect Dis; 2020 Apr; 20(4):411-412. PubMed ID: 32105638
    [No Abstract]   [Full Text] [Related]  

  • 26. Modeling SARS-CoV-2 Positivity Using Laboratory Data: Timing Is Everything.
    Larson T; Culbreath K; Chavez D; Larson R; Crossey M; Grenache DG
    Clin Chem; 2020 Jul; 66(7):981-983. PubMed ID: 32353116
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of seven commercial SARS-CoV-2 RNA detection kits based on real-time polymerase chain reaction (PCR) in China.
    Wang B; Hu M; Ren Y; Xu X; Wang Z; Lyu X; Wu W; Li Z; Gong X; Xiang Z; Tang L; Peng Y; Wang M
    Clin Chem Lab Med; 2020 Aug; 58(9):e149-e153. PubMed ID: 32651975
    [No Abstract]   [Full Text] [Related]  

  • 28. Are SARS-CoV-2 reinfection and Covid-19 recurrence possible? a case report from Brazil.
    Bonifácio LP; Pereira APS; Araújo DCAE; Balbão VDMP; Fonseca BALD; Passos ADC; Bellissimo-Rodrigues F
    Rev Soc Bras Med Trop; 2020; 53():e20200619. PubMed ID: 32965458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 serologic testing: FAQs and caveats.
    Kadkhoda K
    Cleve Clin J Med; 2020 Jun; 87(6):329-333. PubMed ID: 32434807
    [No Abstract]   [Full Text] [Related]  

  • 30. Limits of Detection of 6 Approved RT-PCR Kits for the Novel SARS-Coronavirus-2 (SARS-CoV-2).
    Wang X; Yao H; Xu X; Zhang P; Zhang M; Shao J; Xiao Y; Wang H
    Clin Chem; 2020 Jul; 66(7):977-979. PubMed ID: 32282874
    [No Abstract]   [Full Text] [Related]  

  • 31. Severe COVID-19 disease and thromboinflammation.
    Jerjes-Sánchez C
    Arch Cardiol Mex; 2020; 90(3):257-258. PubMed ID: 32952161
    [No Abstract]   [Full Text] [Related]  

  • 32. Initial Observations with Molecular Testing for COVID-19 in a Private Hospital in Mumbai, India.
    Shah S; Singhal T; Davar N; Thakkar P
    Indian J Pediatr; 2020 Jul; 87(7):555. PubMed ID: 32378133
    [No Abstract]   [Full Text] [Related]  

  • 33. COVID-19 in MS and NMOSD: A multicentric online national survey in Chile.
    Ciampi E; Uribe-San-Martín R; Soler B; Fernández R; García P; Navarrete-Asenjo C; Tirapegui JM; Torres R; Polanco J; Suárez F; Cuello MJ; Cárcamo C
    Mult Scler Relat Disord; 2020 Oct; 45():102392. PubMed ID: 32683306
    [No Abstract]   [Full Text] [Related]  

  • 34. Rising to the Challenge: Otolaryngologists in the COVID-19 Pandemic.
    Patel ZM
    Otolaryngol Clin North Am; 2020 Dec; 53(6):xxvii-xxviii. PubMed ID: 33127044
    [No Abstract]   [Full Text] [Related]  

  • 35. The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports").
    Persad G; Emanuel EJ
    JAMA; 2020 Jun; 323(22):2241-2242. PubMed ID: 32374357
    [No Abstract]   [Full Text] [Related]  

  • 36. Herd immunity and COVID-19.
    Chen J; Ye L; Zhou MY; Cheng YR; Wang MW; Feng ZH
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4064-4065. PubMed ID: 32374011
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of a high-speed but low-throughput RT-qPCR system for detection of SARS-CoV-2.
    Sakai J; Tarumoto N; Orihara Y; Kawamura R; Kodana M; Matsuzaki N; Matsumura R; Ogane K; Kawamura T; Takeuchi S; Imai K; Murakami T; Maesaki S; Maeda T
    J Hosp Infect; 2020 Aug; 105(4):615-618. PubMed ID: 32446722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Several potential risks of novel coronavirus (COVID-19) pneumonia outbreaks in hospitals.
    Wen X; Ling C; Li Y
    Am J Infect Control; 2020 Jun; 48(6):730. PubMed ID: 32291103
    [No Abstract]   [Full Text] [Related]  

  • 39. Covid 19: death certification in England and Wales.
    Luce T
    BMJ; 2020 Apr; 369():m1571. PubMed ID: 32317252
    [No Abstract]   [Full Text] [Related]  

  • 40. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis and Myelitis in COVID-19.
    Zhou S; Jones-Lopez EC; Soneji DJ; Azevedo CJ; Patel VR
    J Neuroophthalmol; 2020 Sep; 40(3):398-402. PubMed ID: 32604245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.